Regentis Biomaterials Ltd. (RGNT)
NYSEAMERICAN: RGNT · Real-Time Price · USD
3.930
-0.460 (-10.48%)
At close: Feb 17, 2026, 4:00 PM EST
4.000
+0.070 (1.78%)
After-hours: Feb 17, 2026, 8:00 PM EST
Regentis Biomaterials Market Cap
Regentis Biomaterials has a market cap or net worth of $20.35 million as of February 17, 2026.
Market Cap
20.35M
Enterprise Value
28.33M
1-Year Change
n/a
Ranking
Category
Stock Price
3.93
Market Cap Chart
Since the IPO on December 4, 2025, Regentis Biomaterials's market cap has decreased from $39.44M to $20.35M, a decrease of -48.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 20.35M | -41.69% |
| Dec 31, 2025 | 34.91M | -11.48% |
| Dec 4, 2025 | 39.44M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Modular Medical | 35.22M |
| TELA Bio | 35.14M |
| Myomo | 31.53M |
| VolitionRx | 30.73M |
| Phaos Technology Holdings (Cayman) Limited | 30.56M |
| Baird Medical Investment Holdings | 28.28M |
| Nortech Systems | 26.19M |
| Inspira Technologies Oxy B.H.N. | 24.19M |